Tenax Therapeutics (TENX) Total Liabilities (2011 - 2026)

Tenax Therapeutics' Total Liabilities history runs 16 years deep, the most recent figure standing at $8.5 million for Q1 2026.

• In Q1 2026, Total Liabilities rose 206.58% year-over-year to $8.5 million; the TTM figure through Mar 2026 stood at $8.5 million (up 206.58% YoY), while the FY2025 annual figure was $7.2 million, up 52.48% from the prior year.
• Total Liabilities came in at $8.5 million for Q1 2026 at Tenax Therapeutics, up from $7.2 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $8.5 million in Q1 2026 to a low of $602214.0 in Q3 2023.
• A 5-year average of $3.0 million and a median of $2.1 million in 2022 frame the typical range for Total Liabilities.
• Across the five-year window, Total Liabilities plunged 53.58% in 2023 and surged 325.38% in 2024, its largest moves.
• Tenax Therapeutics' Total Liabilities stood at $1.9 million in 2022, then soared by 87.61% to $3.6 million in 2023, then surged by 30.83% to $4.7 million in 2024, then surged by 52.48% to $7.2 million in 2025, then increased by 18.59% to $8.5 million in 2026.
• According to Business Quant data, Total Liabilities over the past three periods registered $8.5 million, $7.2 million, and $6.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison